Advantage Investment Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$4K Hold
79
﹤0.01% 787
2019
Q2
$4K Hold
79
﹤0.01% 797
2019
Q1
$4K Hold
79
﹤0.01% 791
2018
Q4
$3K Hold
79
﹤0.01% 851
2018
Q3
$3K Sell
79
-863
-92% -$34.9K ﹤0.01% 900
2018
Q2
$37K Hold
942
0.03% 418
2018
Q1
$35K Hold
942
0.01% 447
2017
Q4
$40K Sell
942
-431
-31% -$17.2K 0.01% 444
2017
Q3
$50K Buy
1,373
+11
+0.8% +$444 0.02% 391
2017
Q2
$62K Buy
1,362
+15
+1% +$662 0.02% 319
2017
Q1
$57K Buy
+1,347
New +$54.9K 0.02% 312

Other funds holding HOLX

Advantage Investment Management's HOLX Position: Q3 2019 in Review

Advantage Investment Management held its Hologic (HOLX) position steady in Q3 2019 at 79 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #787.

Advantage Investment Management first reported a position in HOLX in Q1 2017 and has held it in 11 quarters since. The position peaked at $62K in Q2 2017. 493 funds tracked by Wall St. Rank hold HOLX as of Q3 2019.

  • Advantage Investment Management held 79 shares of Hologic worth $4K as of Q3 2019.
  • Advantage Investment Management left its Hologic share count unchanged in Q3 2019.
  • Hologic made up ﹤0.01% of Advantage Investment Management's portfolio in Q3 2019, its #787 holding.
  • Advantage Investment Management first reported a position in Hologic in Q1 2017 and has held it in 11 quarters since.
  • Advantage Investment Management's Hologic position peaked at $62K in Q2 2017.
  • 493 funds tracked by Wall St. Rank held Hologic as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.